Avidity Biosciences Inc.
- Biotech or pharma, therapeutic R&D
Avidity is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases
Address
San DiegoCalifornia
United States
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}